Published on
The 2018 Recommended Immunization Schedule for Adults Aged 19 or Older from the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) includes a couple of key changes especially relevant to urgent care providers who offer immunization services. As of now, among other updates, ACP recommends:
- Recombinant zoster vaccine (RZV; Shingrix) to prevent shingles in adults as follows:
- Two doses of RZV 2 to 6 months apart to adults age ≥50 years and older with competent immune systems regardless of a history of herpes zoster or receipt of the zoster vaccine live (ZVL; Zostavax)
- Two doses of RZV 2 to 6 months apart to previous recipients of ZVL at least 2 months after ZVL
- For persons age ≥60 years and older, administer RZV or ZVL, with RZV the preferred option
- An additional dose of measles, mumps, and rubella (MMR) vaccine during a mumps outbreak to at-risk adults previously vaccinated with ≤2 doses of a mumps-containing vaccine. The ACIP stresses this should not be a determination made by an individual provider, but at the discretion of public health officials during a mumps outbreak (which readers of JUCM News may recall occurred in various populations, including dorm-living college students on various campuses, last year).
The complete schedule is available on the Annals of Internal Medicine website.
CDC’s 2018 Vaccine Schedule Reflects New Developments in Herpes Zoster, Mumps